Global Innovative Platforms Inc. · OTC:GIPL
Global Innovative Platforms — Investor Presentation (June 2025)
20 slides from Global Innovative Platforms's investor presentation, Jun 23, 2025
Slide 1: Vet Breath Analytics
Vet Breath Analytics a Global Innovative Platforms Inc. (GIPL) division 1) \\\ \\ | Ww Revolutionizing Animal Health through Breath Analysis. —2
Slide 2: Forward Looking Statement
Forward Looking Statement This presentation includes "forward-looking statements." To the extent that the information presented in this presentation discusses financial projections, information, or expectations about our business plans, results of operations, products or markets, or otherwise makes
Slide 3: Introduction
Introduction Vet Breath Analytics (a GIPL division) is transforming animal health with cutting-edge, non- invasive technologies. VBA addresses critical challenges and gaps across veterinary diagnostics. —2> =; Disease Treatment Air Quality Detection Effectiveness Monitoring With advanced gas chromat
Slide 4: Our Mission & Vision
Our Misson & Vision Our Mission To lead the way in breath analytic diagnostics by creating the first breath test for animals, starting with heartworms in dogs. Our revolutionary technology will seek to identify a wide range of animal health issues, from a myriad of diseases to toxic environmental co
Slide 5: Animal health faces critical challenges in detecting diseases early
Animal health prot monitoring treat a gap in proactive Late Detection Many diseases are diagnosed only after significant progression, reducing treatment success rates. face critical challenges in dete: ively. Limited options for non-invasive, first-line screening create Limited Screening Options Non
Slide 6: Our Solution: Breath & Air Analysis using VOCAM+ & FROG
Our Solution: Breath & Air Analysis using VOCAM+ & FROG We believe, the VOCAM+ and FROG technologies offer unprecedented diagnostic and monitoring capabilities, which have the ability to serve veterinarians, herd health managers, environmental health specialists, and other professionals dedicated to
Slide 7: Technology Overview: VOCAM+
Technology Overview: VOCAM+ Advanced Breath Analysis Purpose ¢ Designed for direct breath sampling in animals. ¢ Detects organic compounds (VOCs) to identify early disease markers. Functionality e After breath collection, VOCAM Plus uses gas chromatography and Al-driven analysis to process the sampl
Slide 8: Technology Overview: FROG
Versatile Detection Routes Technology Overview: FROG The FROG-5000 is a compact, portable gas chromatograph (GC) Porta ble Gas Ch romatog ra ph that uses a photoionization detector (PID) for VOC analysis in air, water, and soil samples. Portable & Self-Sufficient Specialized for environmental sampli
Slide 9: Core Areas of Innovation
Core Areas of Innovation VBA’s technology drives innovation across three critical areas: disease detection, treatment effectiveness, and air quality monitoring— addressing key challenges in animal health and safety with non-invasive, rapid solutions. Disease Detection Breath-based diagnostics enable
Slide 10: Perpetual, Exclusive, Lifetime Licensing
Perpetual, Exclusive, Lifetime Licensing Vet Breath Analytics partnered with Defiant Technologies, a leader in portable gas chromatograph (GC) systems, to license their advanced micro-GC technology. This agreement provides access to cutting-edge chemical detection capabilities for veterinary diagnos
Slide 11: AI-Driven Diagnostics
a Al-Driven Diagnostics Veterinary Breath Analytics (VBA) integrates advanced Al to ] revolutionize non-invasive diagnostics, delivering rapid, scalable, ] eg highly accurate insights for animal health., ,0# { , ” , ° z \ | 5 J 7 \, 744,°"8 ‘ | | i \ | ‘ Continuous Rapid Scalable Comprehensive Learn
Slide 12: Companion Animal and Livestock Diagnostics Market Opportunity
Companion Animal US Diagnostics Market $2.88 billion in 2023 and is projected to to $4.28 billion by 2029 (CAGR of 6.8%) Growth Drivers © Growing chronic disease rates in pets e Advances in molecular diagnostics © Increased pet ownership ¢ Demand for rapid, in-house testing options Livestock & Large
Slide 13: Clinical Validation: Disease Detection
Clinical Validation: Disease Detection Vet Breath Analytics began its clinical validation with heartworm disease, leveraging breath analysis to detect early-stage infections. This innovative approach has the potential to expand into detecting other diseases such as hookworms, roundworms, whipworms,
Slide 14: Foundational Research: Heartworm Detection
Foundational Research: Heartworm Detection Auburn University researchers, including Dr. Lindsay Starkey and Dr. Byron Blagburn, have developed a non-invasive, painless method for detecting heartworm infections in dogs. This innovative approach utilizes gas chromatography to analyze volatile organic
Slide 15: Timeline & Milestones
Timeline & Milestones Licensing Canine Breath Heartworm Early Detection Agreement Capture Device Infection Detection Samples Formal agreement with Developed prototype Sample collection and data Sample collection and data analysis Defiant Technologies for breath sample analysis for clinical validatio
Slide 16: Path to Commercialization
Path to Commercialization VBA’s commercialization strategy focuses on field research and strategic partnerships to advance its three core areas of innovation, paving the way for licensing or acquisition by established industry leaders. Disease Detection © Validate technology through field testing. o
Slide 17: Competitive Set
Competitive Set Veterinary Diagnostics ¢ IDEXX, ANTECH & Zoetis Diagnostics: leading providers of Vet Breath Analytics (VBA) diagnostic products and services for animal health, including stands alone in the market, laboratory services and point-of-care testing. pioneering non-invasive diagnostics fo
Slide 18: VBA and Global Innovative Platforms, Inc. (GIPL)
VBA and Global Innovative Platforms, Inc. (GIPL) Vet Breath Analytics (VBA) is a wholly owned subsidiary of Global Innovative Platforms, Inc. (GIPL), a publicly traded company focused on advancing animal health through cutting-edge technology. Transparency Strategic Investor Focus Advantages Operati
Slide 19: Our Team
Our Team Andrew Brown CEO Andrew co-founded and scaled Doorstep Delivery, merging it with BiteSquad to create a $321M deal. With expertise in business development and strategic growth, Andrew leads VBA in transforming animal health diagnostics. Rob Tavzel, MBA, PMP M.Tech.Mgmt. Key Technical Advisor
Slide 20: Thank You
Thank You Contact Us Phone Number 321.230.3739 Address 149 James Place, Maitland, FL 32751 Email Address fo) XX) Andrew@GIPLinc.com 20
Global Innovative Platforms — Investor Presentation (June 2025) on 6ix